Infections by emerging serogroups of Neisseria meningitidis: A case report

Enferm Infecc Microbiol Clin (Engl Ed). 2019 Feb;37(2):142-143. doi: 10.1016/j.eimc.2018.03.009. Epub 2018 May 1.

[Article in English, Spanish]

Authors

Felipe Pérez-García¹, Raquel Abad², Cristina Almirall³, Elena Abarca³

Affiliations

¹ Department of Clinical Analysis, Universitary Hospital HM Sanchinarro, Madrid, Spain. Electronic address: [email protected].
² Reference Laboratory for Meningococci, National Centre of Microbiology, Institute of Health Carlos III, Majadahonda, Spain.
³ Department of Clinical Analysis, Universitary Hospital HM Sanchinarro, Madrid, Spain.

PMID: 29724617
DOI: 10.1016/j.eimc.2018.03.009

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use
Bacteremia / complications
Bacteremia / drug therapy
Bacteremia / microbiology*
Cefotaxime / therapeutic use
Communicable Diseases, Emerging / drug therapy
Communicable Diseases, Emerging / epidemiology
Communicable Diseases, Emerging / microbiology*
Community-Acquired Infections / drug therapy
Community-Acquired Infections / epidemiology
Community-Acquired Infections / microbiology*
Disease Notification
Dyspnea / etiology
Female
Humans
Incidence
Meningococcal Infections / complications
Meningococcal Infections / drug therapy
Meningococcal Infections / epidemiology
Meningococcal Infections / microbiology*
Neisseria meningitidis / classification
Neisseria meningitidis / isolation & purification*
Serotyping
Spain / epidemiology

Substances

Anti-Bacterial Agents
Cefotaxime